A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...

A large study of electronic health records has uncovered four common patterns of medical conditions that tend to unfold in ...

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...

Indianapolis: Eli Lilly and Company has received approval from the U.S. Food and Drug Administration (FDA) for a label update ...

In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.

For Your Patients: Navigating Treatment Options in Early Stage Alzheimer’s Disease — Medications are available to stabilize symptoms and even delay progression ...

The study, which analyzed data on 1.2 million people with dementia, found improvements in five out of eight global regions ...

Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee ...